BOHEMIA, N.Y., Nov. 5 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced results
for the fiscal fourth quarter and fiscal year ended September 30,
2007. For the fiscal fourth quarter ended September 30, 2007, net
sales were $496 million compared to net sales of $468 million for
the fiscal fourth quarter ended September 30, 2006, an increase of
$29 million, or 6%. Net income for the fiscal fourth quarter ended
September 30, 2007 was $48 million, or $0.70 per diluted share,
compared to net income of $38 million, or $0.54 per diluted share
for the fiscal fourth quarter ended September 30, 2006. The rise in
net income for the fiscal fourth quarter reflects the
aforementioned sales increase, gross profit improvement and
SG&A cost controls. Net sales increased $29 million; gross
profit increased to 52% in the fiscal fourth quarter 2007 from 49%
in the fiscal fourth quarter 2006; and SG&A costs as a
percentage of sales decreased to 31.9% in the fiscal fourth quarter
2007 from 32.5% in the fiscal fourth quarter 2006. Adjusted EBITDA
for the fiscal fourth quarter rose to $87 million from $70 million
for the fiscal fourth quarter of 2006. Results for the fiscal
fourth quarter ended September 30, 2007 include an impairment
charge of approximately $2 million, after tax, or $0.03 per diluted
share, to reflect the current fair market value of a building in
Augusta, Georgia, which is currently offered for sale. Without this
charge, earnings per share for the fiscal fourth quarter of 2007
would have been $0.73 per diluted share. For the fiscal year ended
September 30, 2007, net sales were $2.0 billion, compared to net
sales of $1.9 billion for the prior fiscal year, an increase of
$134 million, or 7%. Net income for the fiscal year ended September
30, 2007 was $208 million, or $3.00 per diluted share, compared to
$112 million, or $1.62 per diluted share, for the prior like
period. Adjusted EBITDA for fiscal 2007 rose to $378 million from
$249 million for fiscal 2006. At September 30, 2007, NBTY had
working capital of $575 million, of which $214 million consisted of
cash and short term investments, and total assets of $1.5 billion.
NBTY purchased, in open market transactions, 716,000 shares of its
common stock; 421,000 shares were acquired in the fiscal fourth
quarter 2007 for approximately $15 million and an additional
295,000 shares were acquired in October 2007 for approximately $10
million. These shares were purchased under an existing
publicly-announced authorization. Preliminary and unaudited net
sales for October 2007 were $175 million. A detailed breakdown is
shown in the last table. OPERATIONS FOR THE FISCAL FOURTH QUARTER
ENDED SEPTEMBER 30, 2007 The Wholesale/US Nutrition division
continues to generate increased sales and significantly contributed
to NBTY's overall strong performance. Net sales for the
Wholesale/US Nutrition division, which markets Nature's Bounty,
Solgar, Osteo Bi-Flex, Rexall, Ester-C and other brands, increased
$19 million, or 9%, to $237 million from $217 million for the prior
like quarter. During the fiscal fourth quarter of 2007, gross
profit for the Wholesale/US Nutrition operation increased to 41%
compared to 35% for the prior like quarter. The Company experienced
higher purchase prices of certain products including whey protein
during the fiscal fourth quarter 2007. The Company anticipates
passing on these higher prices to customers in fiscal 2008. The
Wholesale/US Nutrition division utilizes valuable consumer
preference sales data generated by the Company's Vitamin World
retail stores and Puritan's Pride Direct Response/E-Commerce
operations to empower its wholesale customers with this latest
data. The Vitamin World stores are used as a laboratory for new
ideas and are an effective tool in determining and monitoring
consumer preferences. This information, as well as scanned sales
data from the Vitamin World stores, is shared on a real time basis
with our wholesale customers to give them a competitive advantage.
Net sales for the North American Retail division increased $1
million, or 2%, to $57 million from $56 million for the fiscal
fourth quarter ended September 30, 2006. Vitamin World was
profitable for the current fiscal quarter. However, LeNaturiste,
the Company's Canadian retail chain, continued to operate at a loss
during this period. Same store sales for North American Retail
increased 5% for the fiscal fourth quarter of 2007. The North
American Retail division is operating under new management who are
focused on rationalizing SKU's, enhancing visual merchandising and
increasing customer traffic. During the fiscal fourth quarter of
2007, Vitamin World closed 3 under-performing stores and
LeNaturiste closed 5 stores. European Retail net sales for the
fiscal fourth quarter of 2007 increased $13 million, or 9%, to $155
million from $142 million for the fiscal fourth quarter of 2006.
European retail net sales in local currency increased 1% for the
fiscal fourth quarter of 2007. European Retail division continues
to operate in a difficult environment. During the fiscal fourth
quarter, the European Retail division opened 4 stores. This
division anticipates opening 34 new stores during fiscal 2008 in
high street locations that have recently become available. Net
sales from Direct Response/E-Commerce operations for the fiscal
fourth quarter of 2007 decreased $5 million, or 10%, to $47 million
from $52 million for the fiscal fourth quarter of 2006. The Company
is focused on maintaining its market share in this segment;
accordingly, prices were lowered in response to a highly
competitive environment. More orders were received than in the
prior like period. However, because of lowered prices, the average
order size at Puritan's Pride decreased to $62 from $73. Since
Puritan's Pride varies its promotional strategy throughout the
fiscal year, the results for this division should be viewed on an
annual and not quarterly basis. Online sales represent 40% of total
Direct Response/E-Commerce sales for this fiscal fourth quarter
compared to 34% in the prior like quarter. This increase reflects
on-going efforts to garner greater online consumer sales and to
capitalize on the continuing surge in shopping via the web.
Puritan's Pride views the Internet as the driver of future growth
and continues to incorporate new technologies to expand this
business. Puritan's Pride remains the leader in the direct response
and e-commerce sectors and continues to increase the number of
products available via its catalog and web sites. OPERATIONS FOR
THE FISCAL YEAR ENDED SEPTEMBER 30, 2007 Net sales for the
Wholesale/US Nutrition division increased $92 million, or 10%, to
$977 million from $885 million for fiscal year 2006. Gross profit
for the Wholesale operation increased to 41% compared to 32% for
the prior like fiscal year, reflecting in part more efficient
supply chain management. Net sales for the North American Retail
division decreased $11 million, or 5%, to $223 million from $234
million for fiscal year 2006. North American Retail same store
sales increased 1% for fiscal 2007. At the end of fiscal 2007, the
North American Retail division operated a total of 537 stores, with
457 in the US and 80 in Canada. European Retail net sales for the
fiscal year increased $55 million, or 10%, to $620 million for the
fiscal year 2007 from $565 million for the fiscal year 2006.
European Retail same store sales in local currency decreased 1% but
increased 8% in US dollars for fiscal 2007. The European Retail
business continues to leverage its premier status, high street
locations and brand awareness. As of September 30, 2007, the
European Retail business operated a total of 626 stores, comprised
of 507 Holland & Barrett stores and 31 GNC stores in the UK, 19
Nature's Way stores in Ireland, and 69 DeTuinen stores in the
Netherlands. Net sales from Direct Response/E-Commerce operations
for the fiscal year 2007 decreased $2 million, or 1% to $194
million from $196 million for the fiscal year 2006. The decrease in
sales reflects the aforementioned lowering of prices to garner
greater market share in a highly competitive environment. Online
sales represent 38% of total Direct Response/E-Commerce sales for
this fiscal year 2007 compared to 33% for fiscal year 2006. NBTY
Chairman and CEO, Scott Rudolph, said: "Our significant increases
in revenue and profitability are reflected in NBTY's ongoing
initiatives to drive sales and expand our premiere position as the
leading nutritional supplement company in the world. Our growing
financial strength and expanding market position continue to play a
vital role in our ability to generate future growth and shareholder
value." ABOUT NBTY NBTY is a leading global vertically integrated
manufacturer, marketer and distributor of a broad line of
high-quality, value-priced nutritional supplements in the United
States and throughout the world. Under a number of NBTY and third
party brands, the Company offers over 22,000 products, including
products marketed by the Company's Nature's Bounty(R)
(http://www.naturesbounty.com/), Vitamin World(R)
(http://www.vitaminworld.com/), Puritan's Pride(R)
(http://www.puritan.com/), Holland & Barrett(R)
(http://www.hollandandbarrett.com/), Rexall(R)
(http://www.rexallsundown.com/), Sundown(R)
(http://www.rexallsundown.com/), MET-Rx(R) (http://www.metrx.com/),
WORLDWIDE Sport Nutrition(R) (http://www.sportnutrition.com/),
American Health(R) (http://www.americanhealthus.com/), GNC(UK)(R)
(http://www.gnc.co.uk/), DeTuinen(R) (http://www.detuinen.nl/),
LeNaturiste(TM) (http://www.lenaturiste.com/), SISU(R)
(http://www.sisu.com/), Osteo Bi-Flex(R)
(http://www.osteobiflex.com/), PureProtein(R)
(http://www.pureprotein.net/), Solgar(R) (http://www.solgar.com/)
and Ester-C(R) (http://www.ester-c.com/) brands. This release
refers to non-GAAP financial measures, such as Adjusted EBITDA.
"ADJUSTED EBITDA" is defined as net income, excluding the aggregate
amount of all non-cash losses reducing net income, plus interest,
taxes, depreciation and amortization. This non-GAAP financial
measure is not prepared in accordance with generally accepted
accounting principles and may be different from non-GAAP financial
measures used by other companies. Non- GAAP financial measures
should not be considered as a substitute for, or superior to,
measures of financial performance prepared in accordance with GAAP.
A reconciliation of the non-GAAP measure to the comparable GAAP
measure is included in the attached financial tables. Management
believes the presentation of Adjusted EBITDA is relevant and useful
because Adjusted EBITDA is a measurement industry analysts utilize
when evaluating NBTY's operating performance. Management also
believes Adjusted EBITDA enhances an investor's understanding of
NBTY's results of operations because it measures NBTY's operating
performance exclusive of interest and non-cash charges for
depreciation and amortization. Management also provides this
non-GAAP measurement as a way to help investors better understand
its core operating performance, enhance comparisons of NBTY's core
operating performance from period to period and to allow better
comparisons of NBTY's operating performance to that of its
competitors. This release contains certain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 with respect to our financial condition, results
of operations and business. These forward-looking statements can be
identified by the use of terminology such as "subject to,"
"believe," "expects," "plan," "project," "estimate," "intend,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy. Although all of these forward looking
statements are believed to be reasonable, they are inherently
uncertain. Factors which may materially affect such forward-looking
statements include: (i) slow or negative growth in the nutritional
supplement industry; (ii) interruption of business or negative
impact on sales and earnings due to acts of God, acts of war,
terrorism, bio- terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and/or unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economic and
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance and/or the costs of the same; (xiv) exposure to and
expense of defending and resolving product liability and
intellectual property claims and other litigation; (xv) the ability
of NBTY to successfully implement its business strategy; (xvi) the
inability of NBTY to manage its retail, wholesale, manufacturing
and other operations efficiently; (xvii) consumer acceptance of
NBTY's products; (xviii) the inability of NBTY to renew leases for
its retail locations; (xix) the inability of NBTY's retail stores
to attain or maintain profitability; (xx) the absence of clinical
trials for many of NBTY's products; (xxi) sales and earnings
volatility and/or trends for the Company and its market segments;
(xxii) the efficacy of NBTY's Internet and on-line sales and
marketing strategies; (xxiii) fluctuations in foreign currencies,
including the British Pound, the Euro and the Canadian dollar;
(xxiv) import-export controls on sales to foreign countries; (xxv)
the inability of NBTY to secure favorable new sites for, and delays
in opening, new retail and manufacturing locations; (xxvi)
introduction of and compliance with new federal, state, local or
foreign legislation or regulation or adverse determinations by
regulators anywhere in the world (including the banning of
products) and more particularly Good Manufacturing Practices in the
United States, the Food Supplements Directive and Traditional
Herbal Medicinal Products Directive in Europe and Section 404
requirements of the Sarbanes- Oxley Act of 2002; (xxvii) the mix of
NBTY's products and the profit margins thereon; (xxviii) the
availability and pricing of raw materials; (xxix) risk factors
discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; (xxx) adverse effects on NBTY as a result of increased
energy prices and potentially reduced traffic flow to NBTY's retail
locations; (xxxi) adverse tax determinations; (xxxii) the loss of a
significant customer of the Company; and (xxxiii) other factors
beyond the Company's control. Readers are cautioned not to place
undue reliance on forward-looking statements. NBTY cannot guarantee
future results, trends, events, levels of activity, performance or
achievements. NBTY does not undertake and specifically declines any
obligation to update, republish or revise forward- looking
statements to reflect events or circumstances after the date hereof
or to reflect the occurrences of unanticipated events.
Consequently, such forward-looking statements should be regarded
solely as NBTY's current plans, estimates and beliefs. Contact:
Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz & Co.
President & Chief Financial Officer 212-725-4500 631-200-2020
NBTY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF
INCOME (UNAUDITED) (In thousands, except per share amounts) For the
three months ended September 30, 2007 2006 Net sales $496,441
$467,912 Costs and expenses: Cost of sales 239,609 238,523
Advertising, promotion and catalog 30,654 23,276 Selling, general
and administrative 158,610 151,910 428,873 413,709 Income from
operations 67,568 54,203 Other income (expense): Interest (3,713)
(4,516) Miscellaneous, net 5,656 1,603 1,943 (2,913) Income before
provision for income taxes 69,511 51,290 Provision for income taxes
21,014 13,627 Net income $48,497 $37,663 Net income per share:
Basic $0.72 $0.56 Diluted $0.70 $0.54 Weighted average common
shares outstanding: Basic 67,235 67,206 Diluted 69,245 69,242 NBTY,
INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED) (In thousands, except per share amounts) For the fiscal
years ended September 30, 2007 2006 Net sales $2,014,506 $1,880,222
Costs and expenses: Cost of sales 966,784 992,197 Advertising,
promotion and catalog 120,126 103,614 Selling, general and
administrative 619,995 598,742 Trademark impairment - 10,450
1,706,905 1,705,003 Income from operations 307,601 175,219 Other
income (expense): Interest (16,749) (25,924) Miscellaneous, net
13,124 3,532 (3,625) (22,392) Income before provision for income
taxes 303,976 152,827 Provision for income taxes 96,044 41,042 Net
income $207,932 $111,785 Net income per share: Basic $3.09 $1.66
Diluted $3.00 $1.62 Weighted average common shares outstanding:
Basic 67,268 67,199 Diluted 69,404 69,130 SALES (Unaudited) THREE
MONTHS ENDED FISCAL YEARS ENDED SEPTEMBER 30, SEPTEMBER 30,
Percentage Percentage (In thousands) 2007 2006 Change 2007 2006
Change Wholesale / US Nutrition $236,941 $217,484 9% $976,814
$885,146 10% North American Retail 57,033 56,105 2% 223,435 234,215
-5% European Retail 155,072 141,888 9% 620,281 564,933 10% Direct
Response / E-Commerce 47,395 52,435 -10% 193,976 195,928 -1% Total
$496,441 $467,912 6% $2,014,506 $1,880,222 7% GROSS PROFIT
PERCENTAGES (Unaudited) THREE MONTHS ENDED FISCAL YEARS ENDED
SEPTEMBER 30, SEPTEMBER 30, Percentage Percentage 2007 2006 Change
2007 2006 Change Wholesale / US Nutrition 41% 35% 6% 41% 32% 9%
North American Retail 59% 59% 0% 59% 58% 1% European Retail 64% 63%
1% 64% 62% 2% Direct Response / E-Commerce 57% 58% -1% 60% 59% 1%
Total 52% 49% 3% 52% 47% 5% ADJUSTED EBITDA** Reconciliation of
GAAP Measures to Non-GAAP Measures ** (Unaudited) (In thousands)
THREE MONTHS ENDED SEPTEMBER 30, 2007 Pretax Depreciation Income
and Non-cash Adjusted (Loss) amortization Interest charges EBITDA**
Wholesale / US Nutrition $43,852 $2,731 $- $- $46,583 North
American Retail 745 854 202 1,801 European Retail 37,874 2,821
40,695 Direct Response / E-Commerce 10,828 1,248 12,076 Segment
Results 93,299 7,654 - 202 101,155 Corporate / Manufacturing
(23,788) 5,910 3,713 - (14,165) Total $69,511 $13,564 $3,713 $202
$86,990 THREE MONTHS ENDED SEPTEMBER 30, 2006 Pretax Depreciation
Income and Non-cash Adjusted (Loss) amortization Interest charges
EBITDA** Wholesale / US Nutrition $27,661 $2,550 $- $(128) $30,083
North American Retail 199 1,188 - 736 2,123 European Retail 34,283
2,843 - - 37,126 Direct Response / E-Commerce 14,202 1,261 - -
15,463 Segment Results 76,345 7,842 - 608 84,795 Corporate /
Manufacturing (25,055) 6,222 4,516 - (14,317) Total $51,290 $14,064
$4,516 $608 $70,478 ** SINCE ADJUSTED EBITDA IS NOT A MEASURE OF
PERFORMANCE CALCULATED IN ACCORDANCE WITH U.S. GENERALLY ACCEPTED
ACCOUNTING PRINCIPLES ("GAAP"), IT SHOULD NOT BE CONSIDERED IN
ISOLATION OF, OR AS A SUBSTITUTE FOR OR SUPERIOR TO, OTHER MEASURES
OF FINANCIAL PERFORMANCE PREPARED IN ACCORDANCE WITH GAAP, SUCH AS
OPERATING INCOME, NET INCOME AND CASH FLOWS FROM OPERATING
ACTIVITIES. IN ADDITION, THE COMPANY'S DEFINITION OF ADJUSTED
EBITDA IS NOT NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES
REPORTED BY OTHER COMPANIES. ADJUSTED EBITDA** Reconciliation of
GAAP Measures to Non-GAAP Measures ** (Unaudited) (In thousands)
FISCAL YEAR ENDED SEPTEMBER 30, 2007 Pretax Depreciation Income and
Non-cash Adjusted (Loss) amortization Interest charges EBITDA**
Wholesale / US Nutrition $196,770 $11,062 $- $- $207,832 North
American Retail 2,771 3,883 1,336 7,990 European Retail 156,966
11,154 - 168,120 Direct Response / E-Commerce 50,706 5,030 - 55,736
Segment Results 407,213 31,129 - 1,336 439,678 Corporate /
Manufacturing (103,237) 24,472 16,749 - (62,016) Total $303,976
$55,601 $16,749 $1,336 $377,662 FISCAL YEAR ENDED SEPTEMBER 30,
2006 Pretax Depreciation Income and Non-cash Adjusted (Loss)
amortization Interest charges EBITDA** Wholesale / US Nutrition
$75,823 $10,159 $- $11,370 $97,352 North American Retail 332 4,884
- 3,141 8,357 European Retail 143,456 11,174 - - 154,630 Direct
Response / E-Commerce 52,748 5,051 - - 57,799 Segment Results
272,359 31,268 - 14,511 318,138 Corporate / Manufacturing (119,532)
24,780 25,924 - (68,828) Total $152,827 $56,048 $25,924 $14,511
$249,310 ** SINCE ADJUSTED EBITDA IS NOT A MEASURE OF PERFORMANCE
CALCULATED IN ACCORDANCE WITH U.S. GENERALLY ACCEPTED ACCOUNTING
PRINCIPLES ("GAAP"), IT SHOULD NOT BE CONSIDERED IN ISOLATION OF,
OR AS A SUBSTITUTE FOR OR SUPERIOR TO, OTHER MEASURES OF FINANCIAL
PERFORMANCE PREPARED IN ACCORDANCE WITH GAAP, SUCH AS OPERATING
INCOME, NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES. IN
ADDITION, THE COMPANY'S DEFINITION OF ADJUSTED EBITDA IS NOT
NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES REPORTED BY
OTHER COMPANIES. NBTY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED
BALANCE SHEETS (UNAUDITED) (Dollars and shares in thousands, except
per share amounts) September 30, September 30, 2007 2006 Current
assets: Cash and cash equivalents $92,902 $89,805 Investments
121,382 - Accounts receivable, net 98,454 89,154 Inventories
384,990 354,496 Deferred income taxes 21,441 26,636 Prepaid
expenses and other current assets 54,460 42,261 Total current
assets 773,629 602,352 Property, plant and equipment, net 323,154
309,437 Goodwill 251,753 235,959 Intangible assets, net 157,548
146,169 Other assets 28,851 10,393 Total assets $1,534,935
$1,304,310 Current liabilities: Current portion of long-term debt
$989 $18,660 Accounts payable 71,852 64,211 Accrued expenses and
other current liabilities 125,533 127,768 Total current liabilities
198,374 210,639 Long-term debt, net of current portion 210,106
191,045 Deferred income taxes 61,788 55,276 Other liabilities 8,697
7,918 Total liabilities 478,965 464,878 Commitments and
contingencies Stockholders' equity: Common stock, $0.008 par;
authorized 175,000 shares; issued and outstanding 67,118 shares and
67,212 shares at September 30, 2007 and September 30, 2006,
respectively 537 538 Capital in excess of par 143,244 138,777
Retained earnings 864,852 671,060 Accumulated other comprehensive
income 47,337 29,057 Total stockholders' equity 1,055,970 839,432
Total liabilities and stockholders' equity $1,534,935 $1,304,310
NBTY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOWS (UNAUDITED) (In thousands) For the fiscal year ended
September 30, 2007 2006 Cash flows from operating activities: Net
income $207,932 $111,785 Adjustments to reconcile net income to
cash and cash equivalents provided by operating activities:
Impairments and disposals of property, plant and equipment 4,682
4,420 Depreciation and amortization 55,601 56,048 Foreign currency
transaction (gain) loss (4,878) 1,851 Amortization and write-off of
deferred charges 1,972 4,354 Gain on extinguishment of debt - (425)
Gain on settlement of interest rate swap - (353) Trademark
impairment - 10,450 Allowance for doubtful accounts (1,575) 1,427
Inventory reserves 12,832 8,908 Deferred income taxes (164)
(12,019) Excess income tax benefit from exercise of stock options
(3,294) (15) Changes in operating assets and liabilities, net of
acquisition: Accounts receivable 361 (16,056) Inventories (29,229)
131,469 Prepaid expenses and other current assets (259) 11,105
Other assets (378) 1,954 Accounts payable 1,025 (4,852) Accrued
expenses and other liabilities (3,632) 2,912 Net cash provided by
operating activities 240,996 312,963 Cash flows from investing
activities: Purchase of property, plant and equipment (51,374)
(35,308) Proceeds from sale of property, plant, and equipment 100
1,426 Purchase of available-for-sale investments (449,766) -
Proceeds from sale of available-for-sale investments 328,714 39,900
Cash paid for acquisition, net of cash acquired (37,005) - Cash
collateral securing loan (18,861) - Purchase price settlements, net
(473) 1,845 Purchase of intangible assets - (478) Net cash (used
in) provided by investing activities (228,665) 7,385 Cash flows
from financing activities: Principal payments under long-term debt
agreements and capital leases (888) (312,107) Proceeds from
short-term borrowings - 18,204 Principal payments under the
Revolving Credit Facility - (11,000) Proceeds from borrowings under
the Revolving Credit Facility - 5,000 Proceeds from settlement of
interest rate swap - 353 Payments for financing fees (1,649) -
Excess income tax benefit from exercise of stock options 3,294 15
Proceeds from stock options exercised 1,840 105 Purchase of
treasury stock (subsequently retired) (14,808) - Net cash used in
financing activities (12,211) (299,430) Effect of exchange rate
changes on cash and cash equivalents 2,977 1,605 Net increase in
cash and cash equivalents 3,097 22,523 Cash and cash equivalents at
beginning of year 89,805 67,282 Cash and cash equivalents at end of
year $92,902 $89,805 NBTY's preliminary unaudited net sales results
for the month of October 2007 by segment are as follows: NET SALES
(Preliminary and Unaudited) FOR THE MONTH OF OCTOBER ($ In
Millions) 2007 2006 % Change Wholesale / US Nutrition $88 $87 1%
North American Retail $19 $18 5% European Retail $55 $50 9% Direct
Response/ E-commerce $13 $12 6% Total $175 $168 4% European Retail
net sales in local currency remained unchanged for October 2007.
North American Retail same store sales increased 9% in October
2007. DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, President &
Chief Financial Officer of NBTY, Inc., +1-631-200-2020; or Carl
Hymans of G.S. Schwartz & Co., +1-212-725-4500, Web site:
http://www.nbty.com/
Copyright
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024